L&C BIO Co Ltd Ordinary Shares 290650
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 21,200.00–22,200.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 21,300.00 / KRW 21,450.00
- Market Cap
- KRW 482.05 Bil
- Volume/Avg
- 172,687 / 113,424
Key Statistics
- Price/Earnings (Normalized)
- 84.61
- Price/Sales
- 7.31
- Dividend Yield (Trailing)
- 0.48%
- Dividend Yield (Forward)
- 0.48%
- Total Yield
- 0.62%
Company Profile
L&C BIO Co Ltd manufactures and distributes medical equipment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 117
- Website
- http://www.lncbio.co.kr
Comparables
Valuation
|
Metric
|
290650
|
214150
|
150840
|
|---|---|---|---|
Price/Earnings (Normalized) | 84.61 | 43.22 | — |
Price/Book Value | 3.43 | 10.65 | 4.48 |
Price/Sales | 7.31 | 17.70 | 26.93 |
Price/Cash Flow | 35.14 | 43.58 | — |
Price/Earnings
290650
214150
150840
Financial Strength
|
Metric
|
290650
|
214150
|
150840
|
|---|---|---|---|
Quick Ratio | — | — | — |
Current Ratio | 1.20 | 2.02 | 1.82 |
Interest Coverage | 10.92 | 46.55 | −1.43 |
Quick Ratio
290650
214150
150840
Profitability
|
Metric
|
290650
|
214150
|
150840
|
|---|---|---|---|
Return on Assets (Normalized) | 21.54% | 21.05% | −28.93% |
Return on Equity (Normalized) | 42.03% | 29.26% | −63.47% |
Return on Invested Capital (Normalized) | 25.04% | 22.51% | −23.99% |
Return on Assets
290650
214150
150840
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dzwxgjrx | Ndpsw | $181.1 Bil | |
SYK
| Stryker Corp | Ttfgtdgsfh | Pfwf | $127.5 Bil | |
MDT
| Medtronic PLC | Hmjcpqll | Rpxzm | $113.7 Bil | |
BSX
| Boston Scientific Corp | Ltzytmh | Tbppb | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Qkzwhbrkw | Gjcrjf | $54.3 Bil | |
DXCM
| DexCom Inc | Qcmpjqtkw | Ldx | $52.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Bmrrbbjz | Dthwbcw | $26.4 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Xnmbmhckkp | Zqps | $24.7 Bil | |
ALGN
| Align Technology Inc | Yxbhjsgf | Ymrgmsz | $20.6 Bil | |
PODD
| Insulet Corp | Wztdftmh | Vqqfhhn | $13.1 Bil |